about
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies f...
Read More
13.57
-0.73
(-5.10%)
397.8K
XNAS Volume
XNAS 01 Oct, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
GH Research PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..